- When used as drugs, the
International Nonproprietary Names (INNs) end in -
mab. The
remaining syllables of the INNs, as well as the
column Source, are explained...
- MDX-1097 (formerly
called IST-1097, now
called KappaMab) is a
monoclonal antibody therapy that in 2023 has been ****essed in a
Phase IIb
clinical trial...
-
Theralizumab (also
known as TGN1412, CD28-Super
MAB, and TAB08) is an
immunomodulatory drug
developed by
immunologist Thomas Hünig of the
University of...
- ΔFosB, cAMP
response element binding protein (CREB), and
nuclear factor kappa B (NFκB). ΔFosB
plays a
crucial role in the
development of drug addictions...
- (ΔFosB), cAMP
response element binding protein (CREB), and
nuclear factor-
kappa B (NF-κB). ΔFosB is the most
significant biomolecular mechanism in addiction...
-
Denosumab is an
inhibitor of
RANKL (receptor
activator of
nuclear factor kappa-Β ligand),
which works by
decreasing the
development of osteoclasts, which...
-
fraternities are
Alpha Sigma Pi,
Kappa Gamma and
Kappa Sigma. The
three sororities are
Delta Epsilon, Phi
Kappa Zeta, and
Kappa Theta Phi.
Gallaudet is home...
-
antibodies (mAbs) have
varied therapeutic uses. It is
possible to
create a
mAb that
binds specifically to
almost any
extracellular target, such as cell...
-
including 1,4-butanediol
diacetate (BDDA/DABD), methyl-4-acetoxybutanoate (
MAB), and ethyl-4-acetoxybutanoate (EAB), but
these are, in general, covered...
- (ΔFosB), cAMP
response element binding protein (CREB), and
nuclear factor-
kappa B (NF-κB). ΔFosB is the most
significant biomolecular mechanism in addiction...
